Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/10/2012CN102718703A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities
10/10/2012CN102718676A Agomelatine sulfate and preparation method thereof
10/10/2012CN102716471A Anti-hyperlipidemia health-care product
10/10/2012CN102716451A Oral hypoglycemic liquid prepared by sealwort and bighead atractylodes rhizome
10/10/2012CN102716435A Traditional Chinese medicine feet-soaking preparation for treating diabetic foot
10/10/2012CN102716361A Blood-glucose-lowering and pancreatic-islet-recovering plaster
10/10/2012CN102716342A Medicine for treating diabetes
10/10/2012CN102716313A Anti-dairy cow transport stress pharmaceutical composition
10/10/2012CN102716303A Chinese medicinal composition for treating nephritic syndrome and preparation method thereof
10/10/2012CN102716293A Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease
10/10/2012CN102716283A Hypolipidemic traditional Chinese medicine
10/10/2012CN102716276A Medicine for oral use for treating diabetes
10/10/2012CN102716182A Semen cassiae extract for treating nonalcoholic fatty liver diseases as well as preparation method and application of semen cassiae extract
10/10/2012CN102716174A Novel drug application of cantaloupe seed oil
10/10/2012CN102716154A Processing method and product of ionized calcium water-solubility preparation
10/10/2012CN102716150A Zinc sulfate syrup oral liquid preparation
10/10/2012CN102716149A Calcium carbonate-D3 effervescent tablet and preparation method thereof
10/10/2012CN102716135A Application of lupenone to products for preventing or treating diabetes mellitus
10/10/2012CN102716134A Application of oleanolic acid to medicine for treating obesity
10/10/2012CN102716122A Application of 15-benzal-14-deoxy-11, 12-dehydro-andrographolide derivatives in preparing medicines for treating diabetes mellitus
10/10/2012CN102716102A Mecobalamin tablet and preparation method thereof
10/10/2012CN102716094A Injection pefloxacin mesylate freeze-dried powder composition and preparation method thereof
10/10/2012CN102716087A Vitamin powder and preparation method thereof
10/10/2012CN102716063A Traditional Chinese medicine fat-dissolving slimming cream and production method thereof
10/10/2012CN102715756A Taxus chinensis slow-releasing body-building mattress and manufacturing method
10/10/2012CN102715509A Health care product with function of expelling noxious substances to keep young
10/10/2012CN102715502A Preparation method of health food with the function of anti-diabetes
10/10/2012CN102488772B Chinese herbal composition for preventing or treating hyperlipemia
10/10/2012CN102276683B Smilaxchinoside compound
10/10/2012CN102258622B Traditional Chinese medicine preparation for treating diabetic coronary heart disease and preparation method thereof
10/10/2012CN102258474B Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion
10/10/2012CN102210784B Composition preparation of vitamin E compounds and preparation method thereof
10/10/2012CN102178821B Soft capsules for reducing blood sugar and preparation method thereof
10/10/2012CN102119774B Health-care food suitable for patient with type 2 diabetes mellitus
10/10/2012CN102091131B New application of lotus plumule or extract thereof
10/10/2012CN102018688B PTP1B inhibitor and synthesis and application thereof in preparation of medicine used for treating type II diabetes
10/10/2012CN102000057B Application of 4-cinnamoyl chloride substituted silybin in preparing glycosidase inhibitors
10/10/2012CN101941994B Method for preparing selenium manno-oligosaccharide
10/10/2012CN101934032B Chinese medicinal compound external preparation for treating diabetes and preparation method and application thereof
10/10/2012CN101926891B Composition for losing weight
10/10/2012CN101906156B Structures and application of bifunctional protein and derivatives of bifunctional protein
10/10/2012CN101868251B Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/10/2012CN101857636B Anti-interferon-alpha antibodies
10/10/2012CN101835471B Amine derivative having NPY Y5 receptor antagonist activity
10/10/2012CN101817878B Monomer quick-acting insulin as well as preparing method and application thereof
10/10/2012CN101775349B Health-care vinegar, brewing method and hyperglycemic reduction application thereof
10/10/2012CN101743226B Inhibitors of 11beta-hydroxysteroid dehydrogenase
10/10/2012CN101732363B Auricularia auricular composition and auricularia auricula chewable tablets prepared from same
10/10/2012CN101506139B Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
10/10/2012CN101490064B Novel glucokinase activators and methods of using same
10/10/2012CN101479249B Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
10/10/2012CN101472921B Pyridylisoxazole derivative
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101370796B Thiazoles as 11 beta-HSD1 inhibitors
10/10/2012CN101309689B Dipeptidyl peptidase inhibitors for treating diabetes
10/10/2012CN101263112B Histamine H3 receptor agents, preparation and therapeutic uses
10/10/2012CN101151276B Method of producing protein by using hamster IGF-1
10/10/2012CN101128487B Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
10/10/2012CN101073584B Method and compositions for altering cell function
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283312 Compositions and methods for modulating body weight and treating obesity-related disorders
10/09/2012US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2586239C Methods for regulating weight and size of animals with glycine
10/09/2012CA2573054C Glycogen or polysaccharide storage disease treatment method
10/09/2012CA2563237C Appetite-suppressing compositions and methods
10/09/2012CA2538494C Composition for modulating blood parameters
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2531011C Thiazolylpiperidine derivatives as mtp inhibitors
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135597A2 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair
10/04/2012WO2012135570A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/04/2012WO2012135422A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
10/04/2012WO2012135082A1 Prodrugs of lxr modulating imidazole derivatives
10/04/2012WO2012134590A2 Calcium supplement
10/04/2012WO2012134233A2 Sulphamide derivative having an adamantyl group and a pharmaceutically acceptable salt thereof
10/04/2012WO2012134231A2 Benzamide derivative as cannabinoid receptor (cb1) antagonist
10/04/2012WO2012134172A2 Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
10/04/2012WO2012134005A1 Composition for preventing or treating metabolic disease containing as active ingredient extract of musca domestica l. having ingested sulfur
10/04/2012WO2012133960A1 Inhibitor for dipeptidyl peptidase iv
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012WO2012133693A1 Pharmaceutical combination for diabetes treatment
10/04/2012WO2012133533A1 Agent for improving or maintaining qol
10/04/2012WO2012133005A1 Fat-reducing agent
10/04/2012WO2012131689A1 Insulin mimetic active comprising oxodiperoxo vanadates and a pharamaceutical composition obtained thereof
10/04/2012WO2012131297A1 Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
10/04/2012WO2012131145A1 Serum cholesterol lowering drink and an improved method for lowering cholesterol
10/04/2012WO2012131003A1 Trpm5 inhibitors support body weight reduction without reducing food intake
10/04/2012WO2012130955A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
10/04/2012WO2012130912A1 Compounds for treatment of metabolic syndrome
10/04/2012WO2012130679A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012WO2012130567A1 Method for encapsulated therapeutic products and uses thereof
10/04/2012WO2012130136A1 Glucagon-like peptide-1 analogue monomer and dimer, preparation method therefor and application thereof
10/04/2012WO2012130122A1 Pharmaceutical composition for controlling blood sugar, blood lipid and body weight
10/04/2012WO2012130015A1 Site-directed mono-substituted pegylated exendin analog and preparation method therefor
10/04/2012WO2012129765A1 Method for preparing stable-type vitamin a microcapsules continuously
10/04/2012US20120253041 New phenylalanine derivatives
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 1298